Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Sigma Healthcare Ltd ( (AU:SIG) ).
Sigma Healthcare Ltd reported a significant increase in sales revenue by 45.7% for the year ending January 31, 2025, reaching $4.84 billion. Despite the revenue growth, the company experienced a net loss after tax of $12.9 million, attributed to a decrease in statutory EBIT and net tangible asset backing per share. The company declared no final dividend for the year, reflecting a cautious approach amid financial challenges.
More about Sigma Healthcare Ltd
Sigma Healthcare Ltd operates in the healthcare industry, focusing on the distribution of pharmaceutical products and services. The company is a key player in the Australian market, providing a wide range of healthcare solutions.
YTD Price Performance: 7.01%
Average Trading Volume: 8,058
Technical Sentiment Consensus Rating: Sell
Current Market Cap: €19.7B
Find detailed analytics on SIG stock on TipRanks’ Stock Analysis page.